Insulin Aspart

Known as: B28asp, Insulin, Insulin, Aspartic Acid(B28)-, Insulin Aspart [Chemical/Ingredient] 
Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
There is compelling evidence that intranasal administration of regular human insulin (RH-I) improves memory in humans. Owing to… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The aim of this 52-week, open-label, non-inferiority trial was to compare the safety and efficacy of exenatide (an incretin… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
AIM This observational study in patients with type 2 diabetes failing oral agent therapy with or without basal insulin was… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compared with continuous… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
This trial compared the efficacy and safety of basal-bolus therapy using either the soluble basal insulin analogue insulin… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE The efficacy of the insulin analogs now available for multiple daily injection (MDI) and continuous subcutaneous… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
AIMS To compare the efficacy of insulin aspart, a rapid-acting insulin analogue, with that of unmodified human insulin on long… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To study the pharmacokinetic and pharmacodynamic profile of insulin aspart (a new fast-acting human insulin analog… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE Insulin aspart is a novel rapid-acting insulin analog. This study was performed to compare the postprandial serum… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To compare glycemic control obtained with the new rapid-acting insulin analog insulin aspart with that obtained with… (More)
Is this relevant?